I'm not sure about how much overhead supply there
Post# of 72440
Let's not forget that this is was Stage 2 of the takedown that started when CTIX was threatening the magic 5 mark that would have enabled some institutions to buy this stock. When we appeared to be poised for another run up -- boom --- they dropped the hammer with perfect timing, compliments of Seeking Alpha and the Rosen Law firm.
I ask again, as I repeatedly did on the other site until someone there decided to shut down some of us bullish posters:
WHO PROFITS?
Is it JUST the shorts' gang? We know that this well-orchestrated, well-funded move is not just some guy writing an article that should have been removed by Seeking Alpha's own guidelines (they say they want you to report factual inaccuracies -- yet when many did,, including the company and a researcher who has as he says literally more knowledge about it than anyone else, was it removed? Yes, the shorts have made a huge amount of money -- but why didn't they completely cover at 1.70ish?
We know that nothing has changed for the worse with the science. On the contrary, we have even more progress in clinical trials. 3 drugs in human trials for 4 indications, with tremendous chance of continued success and FDA approval for Brilacidin, and very early mind-blowing anecdotal evidence of efficacy for Kevetrin.
Why would anyone still be short?
Could it be that someone wants the share price down, so that a crappy financing deal or a terrible partnership deal can be forced on the company? Is this only partially about the immediate profits from scaring the stupid out of their shares? Why isn't the raid over?
I wonder, I wonder. But not very much.